CVS Health Corp (CVS)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 11,149,000 | 5,612,000 | 10,432,000 | 9,748,000 | 9,000,000 |
| Revenue | US$ in thousands | 357,776,000 | 322,467,000 | 292,111,000 | 268,706,000 | 256,776,000 |
| Pretax margin | 3.12% | 1.74% | 3.57% | 3.63% | 3.51% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $11,149,000K ÷ $357,776,000K
= 3.12%
The pretax margin of CVS Health Corp has shown fluctuations over the past five years. In 2023, the pretax margin improved to 3.12% from 1.75% in 2022, indicating a significant increase in profitability before accounting for taxes. However, this figure is still lower than the pretax margin in 2021, which stood at 3.57%. In comparison to the year 2020, when the pretax margin was 3.64%, there has been a slight decline in profitability in 2023. Similarly, the pretax margin in 2019 was 3.50%, showing consistency with the current year.
Overall, while there have been fluctuations in pretax margin over the past five years, the recent increase in 2023 suggests an improvement in CVS Health Corp's profitability. Further analysis would be required to understand the factors driving these changes and to assess the company's overall financial health.
Peer comparison
Dec 31, 2023